Retinitis pigmentosa: open trials in China

11 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT05805007
Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa
Trial Treatment · Early phase 1 · Peking University Third Hospital
Peking University Third Hospital, Beijing
Registry updated 2026-10-15
NCT07656753
Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy
Trial Treatment · Early phase 1 · Peking Union Medical College Hospital
Peking Union Medical College Hospital, Beijing
Registry updated 2026-06-18
NCT06952842
Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
Trial Treatment · Phase 1/2 · Chigenovo Co., Ltd
Peking University Third Hospital, Beijing
Registry updated 2026-06-17
NCT07126470
Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
Trial Treatment · Zhongshan Ophthalmic Center, Sun Yat-sen University
Zhongshan Ophthalmic Center,Sun Yat-Sen University, Guangzhou · Shenzhen Eye Hospital, Shenzhen · Wuhan Aier Eye Hospital, Wuhan
Registry updated 2026-04-23
NCT06292650
Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients
Trial Treatment · Early phase 1 · Augelux Therapeutics
Beijing Tongren Hospital of Capital Medical University, Beijing
Registry updated 2026-03-31
NCT07063030
A Study of LX107 Gene Therapy in AIPL1-IRD Patients
Trial Treatment · Early phase 1 · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Registry updated 2026-03-10
NCT07311863
UGX202 Injection in Patients With Advanced Retinitis Pigmentosa
Trial Treatment · Early phase 1 · Suzhou UgeneX Therapeutics Co., Ltd.
Eye ENT Hospital of Fudan University, Shanghai
Registry updated 2025-12-31
NCT05853107
Pilot Study of AuTNA I
Trial Treatment · Eye & ENT Hospital of Fudan University
Chunhui Jiang, Shanghai
Registry updated 2025-09-19
NCT07082855
A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa
Trial Treatment · Phase 3 · Zhongshan Ophthalmic Center, Sun Yat-sen University
Zhongshan Ophthalmic Center,Sun Yat-Sen University, Guangzhou
Registry updated 2025-07-24
NCT06936787
An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa
Trial Treatment · Phase 1 · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai
Registry updated 2025-04-27
NCT05874310
Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
Trial Treatment · Early phase 1 · Frontera Therapeutics
Peking Union Medical College Hospital, Beijing · Eye ENT Hospital of Fudan University, Shanghai
Registry updated 2023-05-24

All Retinitis pigmentosa trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error